FFAR4 and pulmonary emphysema: In summary, the results suggest that overexpression of Ffar4 or treatment with TUG891 can effectively mitigate the decline in lung function, emphysema, airway inflammation, and bronchial epithelial senescence induced by CS exposure in mice.